(Reuters) – The U.S. Food and Drug Administration on Monday classified the recall of Abbott Laboratories’ CentriMag blood pumping system following the death of a patient, as Class 1 or the most serious type of recall.
The CentriMag System pumps blood through a patient for up to six hours during open heart procedures and is also used to provide temporary blood circulatory support to patients for up to 30 days.
